Skip to main content

Find Clinical Trials

Home
Conditions
Mucopolysaccharidoses

Clinical trial condition

Mucopolysaccharidoses

Explore clinical trials studying Mucopolysaccharidoses. Study availability and eligibility vary by location and protocol.

193 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Mucopolysaccharidoses trial results

Completed

Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease

NCT00258011

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations: Osaka City University Hospital Osaka, Japan

National Center for Child Health and Development Tokyo, Japan

View Trial Details

Completed

Psychological Concomitants of Morquio Syndrome (The MAP Study)

NCT01752296

Conditions: Behavior, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Emory University Decatur, Georgia, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage

NCT01475474

Conditions: Bowel Incontinence, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Dr. Segall Los Gatos, California, United States

UCSD Medical Center San Diego, California, United States

Cleveland Clinic Florida Weston, Florida, United States

View Trial Details

Completed

Pregabalin and Colonic Function

NCT01094808

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients

NCT01301898

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +22 more
Locations: Samsung Medical Center Seoul, Irwon-dong, Gangnam-Gu, South Korea

View Trial Details

Completed

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

NCT00299000

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Oakland Oakland, California, United States

Hospital Femme Mere Enfant Centre Lyon, France

Hospital PediAtrico de Coimbra Coimbra, Portugal

View Trial Details

Completed

Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)

NCT01176227

Conditions: Carbohydrate Metabolism, Inborn Errors, Colitis, Mucous, Colon, Irritable, +26 more
Locations: The Canadian College of Naturopathic Medicine Toronto, Ontario, Canada

View Trial Details

Completed

Study of rhASB in Patients With Mucopolysaccharidosis VI

NCT00104234

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Completed

Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

NCT00067470

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Completed

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

NCT00048711

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details